Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1 participants
INTERVENTIONAL
2010-01-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study allows a person with ALS to communicate, control their wheelchair tilt and perform other tasks using a BCI, thus increasing their independence.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A P300 Brain Computer Interface to Operate Power Wheelchair Tilt
NCT01123148
A P300 Brain Computer Interface Keyboard to Control Assistive Technology For Use by People With Amyotrophic Lateral Sclerosis
NCT01119001
P300 Brain Computer Interface Keyboard to Operate Assistive Technology
NCT00860951
Development and Test of a Headset for BCI Until Obtaining an Efficient and Comfortable System That Can be Used in Daily Practice by ALS People
NCT04380649
Brain Computer Interface for Communication in ICU: a Feasibility Study
NCT01005524
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We intended to enroll six participants, but were only able to enroll one.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Brain Computer Interface In-Home Use
Brain Computer Interface for Wheelchair Tilt Control
Patients will be given the BCI for use in-home, as long as they use the BCI at least 10 hours per week and complete monthly performance assessment sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brain Computer Interface for Wheelchair Tilt Control
Patients will be given the BCI for use in-home, as long as they use the BCI at least 10 hours per week and complete monthly performance assessment sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presently having difficulty communicating or operating the controls for assistive technology or likely to have difficulty in the next six months.
* Able to see the BCI display
* Able to understand and remember instructions concerning participation.
* Live in an environment that can accommodate the wheelchair portable BCI host computer
* Expected to live in the same physical environment for at least 6 months.
* Has family and caregiver(s) who are supportive of participation in this research.
* Has a primary caregiver who is technically capable, willing to learn the setup and operation of the BCI system, and likely to remain with the subject for at least 6 months.
* Has been shown to be able to use a BCI (in an experimental session under another IRB, e.g. HUM 00012968).
* Has a clear understanding of the shortcomings of the present state of BCI technology
Exclusion Criteria
* Inability to communicate well enough to give informed consent.
* History of photo-sensitive epilepsy
* Known significant cognitive deficits
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jane Huggins, PhD
Research Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jane Huggins, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
J0002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.